Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

monomycoloyl glycerol

Known as: MMG lipid 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Monoglycerides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Immune responses induced by nano‐self‐assembled lipid adjuvants based on a monomycoloyl glycerol analogue after vaccination with the Chlamydia trachomatis major outer membrane protein
ABSTRACT Nanocarriers based on inverse hexagonal liquid crystalline phases (hexosomes) show promising potential as vaccine… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2018
2018
Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C)
There is an unmet medical need for new subunit vaccines that induce cytotoxic T-lymphocyte (CTL) responses to prevent infection… Expand
  • table 1
  • table 2
Is this relevant?
2018
2018
Targeting the Mincle and TLR3 receptor using the dual agonist cationic adjuvant formulation 9 (CAF09) induces humoral and polyfunctional memory T cell responses in calves
There is a need for the rational design of safe and effective vaccines to protect against chronic bacterial pathogens such as… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
Nano-Self-Assemblies Based on Synthetic Analogues of Mycobacterial Monomycoloyl Glycerol and DDA: Supramolecular Structure and Adjuvant Efficacy.
The mycobacterial cell-wall lipid monomycoloyl glycerol (MMG) is a potent immunostimulator, and cationic liposomes composed of a… Expand
Is this relevant?
2016
2016
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile
A prerequisite for vaccine-mediated induction of CD8+ T-cell responses is the targeting of dendritic cell (DC) subsets… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.
Vaccines inducing cytotoxic T-cell responses are required to achieve protection against cancers and intracellular infections such… Expand
Is this relevant?
2014
2014
A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell response.
AIM To combine the dimethyldioctadecyl ammonium/monomycoloyl glycerol (DDA/MMG) liposomal vaccine adjuvant with the Toll-like… Expand
Is this relevant?
2011
2011
Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo.
The combination of delivery systems such as cationic liposomes and immunopotentiating molecules is a promising approach for the… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
2009
2009
Novel Generation Mycobacterial Adjuvant Based on Liposome-Encapsulated Monomycoloyl Glycerol from Mycobacterium bovis Bacillus Calmette-Guérin1
The immunostimulatory activity of lipids associated with the mycobacterial cell wall has been recognized for several decades and… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species.
The surface-exposed lipids of Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium kansasii, Mycobacterium gastri… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE